Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lon S Schneider

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
The Lancet. Neurology|October 12, 2010
Organising the language of Alzheimer's disease in light of biomarkersLon S Schneider
The New England Journal of Medicine|March 9, 2012
Discontinuing donepezil or starting memantine for Alzheimer's diseaseLon S Schneider
Continuum (Minneapolis, Minn.)|April 6, 2013
Alzheimer disease pharmacologic treatment and treatment researchLon S Schneider
The Lancet. Neurology|October 10, 2014
Idalopirdine for Alzheimer's disease: written in the starsLon S Schneider
The Lancet. Neurology|February 26, 2008
Does donepezil improve executive function in patients with CADASIL?Lon S Schneider
The Lancet. Neurology|August 10, 2019
The risks and uses of dietary supplementsLon S Schneider
The Lancet. Neurology|September 11, 2012
Ginkgo and AD: key negatives and lessons from GuidAgeLon S Schneider
JAMA|June 24, 2004
Estrogen and dementia: insights from the Women's Health Initiative Memory StudyLon S Schneider
The Lancet. Neurology|October 19, 2016
WHO's dementia research priorities: a prescription for failure?Lon S Schneider
Lancet (London, England)|August 1, 2016
Reduce vascular risk to prevent dementia?Lon S Schneider
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
The Lancet. Neurology|October 12, 2010
Organising the language of Alzheimer's disease in light of biomarkersLon S Schneider
The New England Journal of Medicine|March 9, 2012
Discontinuing donepezil or starting memantine for Alzheimer's diseaseLon S Schneider
Continuum (Minneapolis, Minn.)|April 6, 2013
Alzheimer disease pharmacologic treatment and treatment researchLon S Schneider
The Lancet. Neurology|October 10, 2014
Idalopirdine for Alzheimer's disease: written in the starsLon S Schneider
The Lancet. Neurology|February 26, 2008
Does donepezil improve executive function in patients with CADASIL?Lon S Schneider
The Lancet. Neurology|August 10, 2019
The risks and uses of dietary supplementsLon S Schneider
The Lancet. Neurology|September 11, 2012
Ginkgo and AD: key negatives and lessons from GuidAgeLon S Schneider
JAMA|June 24, 2004
Estrogen and dementia: insights from the Women's Health Initiative Memory StudyLon S Schneider
The Lancet. Neurology|October 19, 2016
WHO's dementia research priorities: a prescription for failure?Lon S Schneider
Lancet (London, England)|August 1, 2016
Reduce vascular risk to prevent dementia?Lon S Schneider
Pageof 26